Catalent Committed to Same Standards, Innovative Solutions and Service
SOMERSET, N.J., June 21 /CNW/ - Catalent Pharma Solutions, formerly
Cardinal Health Pharmaceutical Technologies and Services, today announced its
official launch as an independent operating company. The Blackstone Group
acquired the business from Cardinal Health in April 2007.
Catalent is a leading provider of advanced technologies, as well as
development, manufacturing and packaging solutions for pharmaceutical,
biotechnology and consumer healthcare companies in nearly 100 countries.
Catalent offers its customers nearly 75 years of experience in providing
advanced technologies and consistent product supply across nearly every major
dose form type, and holds more than 1,000 patents and patent applications.
Catalent has a long heritage of dose form innovation. Catalent
commercialized softgel capsule technology and Liqui-Gel(R) formulations,
created the "fast dissolve" oral tablet category with Zydis(R), and introduced
the vegetable-based capsule VegiCaps(R) Soft. Catalent's proprietary drug
delivery and packaging technologies and expertise enable customers to achieve
their desired clinical and market outcomes, and are used in many well-known
consumer health and prescription drug products. Catalent is also known for its
child-resistant, senior-friendly and compliance-enhancing packaging designs.
Customers will continue to rely on Catalent and its team of specialized
experts worldwide for its advanced technologies and substantial expertise.
"Catalent intimately understands the global challenges our customers face
while developing and commercializing life-enhancing and life-saving drugs or
innovative consumer health products," said John Lowry, president and CEO of
Catalent Pharma Solutions. "By consistently providing our customers with the
technologies, services and reliable solutions they have come to expect from
us, we enable them to focus on their own core competencies."
The Catalent name was created to combine the ideas embodied by the words
"catalyst" and "talent." Catalent serves as a catalyst for success for its
customers, enabling them to ensure product supply and improve product
effectiveness, while "talent" underscores the company's breadth and depth of
scientific, technical and local market expertise around the world.
Headquartered in Somerset, New Jersey, Catalent is the leading provider
of advanced technologies, and development, manufacturing and packaging
services for pharmaceutical, biotechnology and consumer healthcare companies
in nearly 100 countries. The company applies its local market expertise and
technical creativity to advance treatments, change markets and enhance patient
outcomes. Catalent employs approximately 10,000 at more than 30 facilities
worldwide and generates more than $1.7 billion in annual revenue. For more
information, visit www.catalent.com.
For further information:
For further information: Peppercom for Catalent Brian Gawron,
212-931-6167 firstname.lastname@example.org or Catalent Pharma Solutions Patricia
McGee, 732-537-6407 email@example.com